Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
Infection|May 1, 1987
Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteersG W Welling, G Groen, S Welling-Wester, et al.Journal of Chromatography|July 12, 1991
A ten-residue fragment of an antibody (mini-antibody) directed against lysozyme as ligand in immunoaffinity chromatographyG W Welling, J van Gorkum, R A Damhof, et al.Archives of Virology|January 1, 1993
T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individualsR A Damhof, J W Drijfhout, A J Scheffer, et al.Journal of Chromatography|August 3, 1984
Isolation of detergent-extracted Sendai virus proteins by gel-filtration, ion-exchange and reversed-phase high-performance liquid chromatography and the effect on immunological activityG W Welling, J R Nijmeijer, R van der Zee, et al.Virology|August 12, 1999
Domains of glycoprotein H of herpes simplex virus type 1 involved in complex formation with glycoprotein LD F Westra, H B Kuiperij, G W Welling, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|August 28, 2001
Immobilised metal-ion affinity chromatography purification of histidine-tagged recombinant proteins: a wash step with a low concentration of EDTAD F Westra, G W Welling, D G Koedijk, et al.Journal of Immunological Methods|November 30, 1989
Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein DJ R Van der Ploeg, J W Drijfhout, M Feijlbrief, et al.Journal of Chromatography|July 20, 1990
Synthetic antibody fragment as ligand in immunoaffinity chromatographyG W Welling, T Geurts, J van Gorkum, et al.Archives of Virology|January 1, 1990
Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein DH J Geerligs, M Feijlbrief, M Bolk, et al.Archives of Virology|January 1, 1994
Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodiesS Welling-Wester, M Feijlbrief, D G Koedijk, et al.Pageof 11